Untreated Childhood Acute Lymphoblastic Leukemia: Clinical Trials

7 trials for Untreated Childhood Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 14Completed 4

Follow Untreated Childhood Acute Lymphoblastic Leukemia: new trials by email Literature Review of Untreated Childhood Acute Lymphoblastic Leukemia trials Research Report on Untreated Childhood Acute Lymphoblastic Leukemia

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia
treosulfan, fludarabine phosphate, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center962009-02-012021-06-22
Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML
nilotinib, imatinib mesylate, pharmacological study - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center402008-08-142017-08-10
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
doxorubicin hydrochloride, cyclophosphamide, methotrexate - Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma
Phase 2CompletedChildren's Oncology Group972004-06-012014-09-19
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
fludarabine phosphate, total-body irradiation, mycophenolate mofetil - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center1502004-04-012020-01-29
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
fludarabine phosphate, total-body irradiation, nonmyeloablative allogeneic hematopoietic stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center372003-09-012020-01-18
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
allopurinol, cyclophosphamide, daunorubicin hydrochloride - Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)3022003-06-012022-05-03
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
Fludarabine Phosphate, Total-Body Irradiation, Peripheral Blood Stem Cell Transplantation - Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center1062001-08-012019-12-20

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (6)  ·  Leukemia, Myeloid, Accelerated Phase (4)  ·  Leukemia, Myeloid, Acute (4)  ·  Blast Crisis (3)  ·  Burkitt Lymphoma (3)  ·  Congenital Abnormalities (3)  ·  Dendritic Cell Sarcoma, Interdigitating (3)  ·  Hodgkin Disease (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Leukemia, Myeloid, Chronic-Phase (3)  ·  Leukemia, Myelomonocytic, Chronic (3)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Anemia, Refractory (2)  ·  Carcinoma, Renal Cell (2)

Broader conditions

Hemic and Lymphatic Diseases (7)  ·  Immune System Diseases (7)  ·  Immunoproliferative Disorders (7)  ·  Lymphatic Diseases (7)  ·  Lymphoproliferative Disorders (7)  ·  Neoplasms (7)  ·  Neoplasms by Histologic Type (7)  ·  Hematologic Diseases (6)  ·  Leukemia (6)  ·  Leukemia, Lymphoid (6)  ·  Bone Marrow Diseases (5)  ·  Chronic Disease (5)  ·  Disease Attributes (5)  ·  Leukemia, Myeloid (5)  ·  Pathologic Processes (5)

Interventions

Peripheral Blood Stem Cell Transplantation (4)  ·  Whole-Body Irradiation (4)  ·  fludarabine phosphate (4)  ·  Methotrexate (3)  ·  Mycophenolic Acid (3)  ·  Cyclophosphamide (2)  ·  Cyclosporine (2)  ·  Cytarabine (2)  ·  Filgrastim (2)  ·  Imatinib Mesylate (2)  ·  Leucovorin (2)  ·  Tacrolimus (2)  ·  Vincristine (2)  ·  merphos (2)  ·  Acyclovir (1)

Sponsors

Fred Hutchinson Cancer Center (5)  ·  Children's Oncology Group (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (7)  ·  Italy (3)  ·  Germany (2)

Top investigators

Brenda Sandmaier (2)  ·  Boglarka Gyurkocza (1)  ·  David Maloney (1)  ·  Mitchell Cairo, MD CCRP (1)  ·  Paul Carpenter (1)  ·  Wendy Stock (1)

Results publications

PMID 32499241, PMID 30117142

NIH funding

P30CA015704 (4), P01CA018029 (3), P01CA078902 (1), P01HL036444 (1), U10CA031946 (1), U10CA098543 (1)